Cecília Maria Pereira Rodrigues

PhD (1996) in Pharmacy (Biochemistry), Universidade de Lisboa
Postdoctoral research at University of Minnesota, USA
Full Professor, Faculdade de Farmácia, Universidade de Lisboa
Coordinator, iMed.ULisboa

 

Faculdade de Farmácia, Universidade de Lisboa — Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal

T (+351) 217 946 490
F (+351) 217 946 491
Researcher ID M-3572-2013
Group Researcher ID A-4244-2014
Scopus Author ID 7202508239

Research Interests

Rodrigues leads a group investigating molecular regulatory aspects of cell function in disease processes, spanning from neurodegeneration to cancer, with pioneer studies in bile acid-related research. Her laboratory focuses on identifying mechanism-based molecular targets for therapeutic intervention, using relevant preclinical disease models as well as patient samples, available via collaborations with various hospitals. Transcriptome and proteome profiles are validated using genetic or pharmacological inhibition of specific pathways in in vitro models and in mice. Finally, for evaluation of preclinical therapeutic interventions, molecular bioscreening and mouse models of disease (cancer, metabolic and degenerative) are used. Rodrigues has developed bile acids as a group of promising small molecule modulators of cell death/survival, protected by patents.

Selected Publications

Rodrigues PM, Afonso MB, Simão AL, Carvalho CC, Trindade A, Duarte A, Borralho PM, Machado MV, Cortez-Pinto H, Rodrigues CMP, Castro RE. miR-21 ablation and obeticholic acid ameliorate non-alcoholic steatohepatitis in mice. Cell Death Dis 2017; 8(4): e2748.

Afonso MB, Rodrigues PM, Simão AL, Ofengeim D, Carvalho T, Amaral JD, Gaspar MM, Cortez-Pinto H, Castro RE, Yuan J, Rodrigues CMP. Activation of necroptosis in human and experimental cholestasis. Cell Death Dis 2016; 7(9): e2390.

Morgado AL, Rodrigues CMP, Solá S. MicroRNA-145 regulates neural stem cell differentiation through the Sox2-Lin28/let-7 signaling pathway. Stem Cells 2016; 34: 1386-95.

Castro RE, Ferreira DMS, Borralho PM, Machado MV, Cortez-Pinto H, Rodrigues CMP. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in rat liver and activated by disease severity in human non-alcoholic fatty liver disease. J Hepatol 2013; 58: 119-25.

Rodrigues CMP, Solá S, Nan Z, Castro RE, Ribeiro PS, Low WC, Steer CJ. Tauroursodeoxycholic acid reduces apoptosis and protects against neurologic injury after acute hemorrhagic stroke in rats. Proc Natl Acad Sci USA 2003; 100: 6087-92.